Ellis Investment Partners, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ellis Investment Partners, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$6,0000.0%4,0000.0%0.00%0.0%
Q2 2022$6,000
-71.4%
4,000
-33.3%
0.00%
-60.0%
Q1 2022$21,000
-30.0%
6,000
-1.6%
0.01%
-28.6%
Q4 2021$30,000
+3.4%
6,100
+48.8%
0.01%0.0%
Q3 2021$29,000
-23.7%
4,1000.0%0.01%
-30.0%
Q2 2021$38,000
+100.0%
4,100
+95.2%
0.01%
+100.0%
Q1 2021$19,000
+5.6%
2,100
+5.0%
0.01%0.0%
Q4 2020$18,000
-21.7%
2,0000.0%0.01%
-37.5%
Q3 2020$23,000
+21.1%
2,000
+100.0%
0.01%
+14.3%
Q2 2020$19,0001,0000.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders